CLINICAL PHARMACOLOGY AND THERAPEUTIC ASPECTS OF ANTICANCER DRUGS

Authors

  • Arman Khozhayev Oncologist, Professor, Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
  • Zhamilya Duisebai Clinical pharmacologist, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
  • Elvira Rakhmanberdiyeva Clinical pharmacologist, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
  • Zhanat Ismaiyl Clinical pharmacologist, City Clinical Hospital No. 7, Almaty, Kazakhstan
  • Lazzat Mussilim Clinical pharmacologist, City Hospital of Emergency Care of Almaty, Almaty, Kazakhstan

Keywords:

clinical pharmacology, oncology, anticancer therapy, pharmacokinetics, pharmacodynamics, pharmacogenomics, biomarkers, personalized medicine, drug development, toxicity

Abstract

Cancer is a leading cause of death worldwide, making its treatment a priority in modern medicine. Advances in clinical pharmacology in oncology have significantly improved the efficacy and safety of anticancer therapy, ensuring a personalized approach to each patient. Studying the pharmacokinetics and pharmacodynamics of anticancer drugs, the mechanisms of drug interactions, and the characteristics of drug metabolism are key to optimizing treatment regimens and minimizing toxic effects. Modern clinical pharmacology in oncology aims to integrate data from pharmacogenomics and molecular biology, thereby promoting the development of personalized medicine and improving the quality of life of cancer patients

Published

2026-01-12

How to Cite

Arman Khozhayev, Zhamilya Duisebai, Elvira Rakhmanberdiyeva, Zhanat Ismaiyl, & Lazzat Mussilim. (2026). CLINICAL PHARMACOLOGY AND THERAPEUTIC ASPECTS OF ANTICANCER DRUGS. Scientific Results, (12). Retrieved from https://ojs.scipub.de/index.php/SR/article/view/7623

Issue

No. 12 (2026): Scientific Results

Section

Medical Sciences

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.